Studies of Heritable Disorders of Connective Tissue
Clinical and Molecular Manifestations of Heritable Disorders of Connective Tissue
2 other identifiers
observational
929
1 country
1
Brief Summary
Background: \- Heritable disorders of connective tissue are genetic conditions that can affect the skin and other parts of the body. They are related to mutations in genes that are responsible for building tissues. The symptoms differ among disorders. Researchers want to study which genes may be responsible for different disorders. They will be performing a long-term (up to 10 years) study and a study that requires a single visit. These studies will look at how these disorders affect the body and what genes may cause these conditions. Objectives: \- To perform one-time and long-term studies of people who have heritable disorders of connective tissue. Eligibility: \- Individuals at least 2 years of age who have or may have a heritable disorder of connective tissue. Design:
- Participants will be screened with a physical exam, medical history, and blood samples.
- Participants will be on one of two parts of this study. The longitudinal arm will require long-term study over about 10 years. The mutational analysis arm will involve a single visit.
- Longitudinal arm participants must be at least 12 years of age. They will have study visits at regular intervals for up to 10 years. The tests given at these visits may include all or some of the following:
- Blood, saliva, urine, and skin samples
- Heart and lung function tests
- Magnetic resonance imaging scans of the neck, chest, spine, and abdomen
- Other imaging studies such as x-rays, bone density scans, and ultrasounds
- Questionnaires about sleep, pain, and quality of life
- Photographs of affected areas.
- Mutational analysis arm participants will have a single study visit. They will provide blood and saliva samples. They will provide tissue from a skin biopsy. They will also let the researchers take photos of any affected body parts. They will complete questionnaires about sleep, pain, and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2003
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 21, 2003
CompletedFirst Submitted
Initial submission to the registry
December 27, 2005
CompletedFirst Posted
Study publicly available on registry
December 28, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
January 2, 2015
CompletedApril 5, 2018
January 2, 2015
December 27, 2005
April 4, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Description of natural history of Hereditary Disorders of Connective Tissue (HDCT)
Ongoing
Genetic analysis to identify novel genes that cause HDCT
Ongoing
Biochemical analysis of biospecimens to identify correlations with disease activity and progress
Ongoing
Identification of disease treatment targets
Ongoing
Eligibility Criteria
You may qualify if:
- Individuals and their family members will be offered enrollment if they have an established or suspected diagnosis of Marfan, Stickler, or Ehlers-Danlos syndrome, or Overlap connective tissue disorder.
- Determination of eligibility will be made by review of prior records.
- In some cases, a screening evaluation to establish the diagnosis may be performed subjects may be excluded from further participation if the diagnosis is ruled out. Cytogenetic analysis may be necessary to rule out a chromosomal abnormality that has overlapping features with HDCT.
You may not qualify if:
- Pregnant and nursing women may be limited in their participation in some aspects of the study (e.g. ionizing radiation exposure or MRI) during the time that they are pregnant or nursing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute of Aging, Clinical Research Unit
Baltimore, Maryland, 21224, United States
Related Publications (3)
Ainsworth SR, Aulicino PL. A survey of patients with Ehlers-Danlos syndrome. Clin Orthop Relat Res. 1993 Jan;(286):250-6.
PMID: 8425354BACKGROUNDBeighton P, de Paepe A, Danks D, Finidori G, Gedde-Dahl T, Goodman R, Hall JG, Hollister DW, Horton W, McKusick VA, et al. International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am J Med Genet. 1988 Mar;29(3):581-94. doi: 10.1002/ajmg.1320290316. No abstract available.
PMID: 3287925BACKGROUNDBuysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.
PMID: 2748771BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nazli B McDonnell, M.D.
National Institute on Aging (NIA)
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 27, 2005
First Posted
December 28, 2005
Study Start
January 21, 2003
Study Completion
January 2, 2015
Last Updated
April 5, 2018
Record last verified: 2015-01-02